肝硬化肝移植术后脾功能亢进的研究进展

李慧; 汪根树

doi:10.3969/j.issn.1674-7445.2016.03.017

肝硬化肝移植术后脾功能亢进的研究进展

doi: 10.3969/j.issn.1674-7445.2016.03.017

李慧,
汪根树^,

510630 广州，中山大学附属第三医院肝移植科

基金项目:

广东省科技计划项目 2011B060300002

详细信息

通讯作者:
汪根树，Email：wgsh168@163.com

中图分类号: R617, R657.6⁺3
计量
- 文章访问数: 327
- HTML全文浏览量: 140
- PDF下载量: 10
- 被引次数: 0
出版历程
- 收稿日期: 2016-02-20
- 网络出版日期: 2021-01-19
- 刊出日期: 2016-05-15

摘要

摘要: 脾功能亢进(脾亢)指各种原因造成的表现为脾脏肿大及一种或多种血细胞减少的临床综合征，是肝硬化门静脉高压症的常见严重并发症。肝移植术能够有效缓解大部分肝硬化患者合并的脾亢，极少数顽固性脾亢患者可采用脾切除术、部分脾栓塞术或给予重组人粒细胞集落刺激因子治疗。
- 脾功能亢进 /
- 肝硬化 /
- 肝移植

HTML全文

参考文献(34)

[1]	Egami S, Sugawara Y, Mizuta K, et al. Effect of pediatric living-donor liver transplantation on splenomegaly[J]. Transplantation, 2002, 74(11):1639-1642. doi: 10.1097/00007890-200212150-00026
[2]	Ishigami M, Ishizu Y, Onishi Y, et al. Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology[J]. Springerplus, 2013, 2:374. doi: 10.1186/2193-1801-2-374
[3]	Pradella P, Bonetto S, Turchetto S, et al. Platelet production and destruction in liver cirrhosis[J]. J Hepatol, 2011, 54(5):894-900. doi: 10.1016/j.jhep.2010.08.018
[4]	Noguchi H, Hirai K, Aoki Y, et al. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism[J]. Hepatology, 1995, 22(6):1682-1688. doi: 10.1002/(ISSN)1527-3350
[5]	Coelho JC, Balbinot P, Nitsche R, et al. Change in platelet count in patients with hypersplenism subjected to liver transplantation[J]. Arq Gastroenterol, 2011, 48(3):175-178. doi: 10.1590/S0004-28032011000300004
[6]	Chen TY, Chen CL, Huang TL, et al. Predictive factors for persistent splenomegaly and hypersplenism after adult living donor liver transplantation[J]. Transplant Proc, 2012, 44(3):752-754. doi: 10.1016/j.transproceed.2012.01.044
[7]	Chikamori F, Nishida S, Selvaggi G, et al. Effect of liver transplantation on spleen size, collateral veins, and platelet counts[J]. World J Surg, 2010, 34(2):320-326. doi: 10.1007/s00268-009-0314-x
[8]	Ishifuro M, Horiguchi J, Ohshita A, et al. Remission of splenic volume in the recipient during the course of adult-to-adult living donor liver transplantation: evaluation using multislice computed tomography and semiautomatic software[J]. Transplant Proc, 2009, 41(9):3772-3774. doi: 10.1016/j.transproceed.2009.06.202
[9]	Nascimbene A, Iannacone M, Brando B, et al. Acute thrombocytopenia after liver transplant: role of platelet activation, thrombopoietin deficiency and response to high dose intravenous IgG treatment[J]. J Hepatol, 2007, 47(5):651-657. doi: 10.1016/j.jhep.2007.06.012
[10]	Kaneko J, Sugawara Y, Akamatsu N, et al. Spleen volume and platelet number changes after living donor liver transplantation in adults[J]. Hepatogastroenterology, 2004, 51(55):262-263. http://cn.bing.com/academic/profile?id=2404805843&encoded=0&v=paper_preview&mkt=zh-cn
[11]	Chen Y, Xu F, Hu L, et al. Significance of postoperative changes in hemodynamics and biochemical indices in pediatric recipients of live-donor liver transplants[J]. Transplant Proc, 2013, 45(9):3320-3324. doi: 10.1016/j.transproceed.2013.04.013
[12]	Perkins JD. Profound thrombocytopenia immediately following liver transplantation[J]. Liver Transpl, 2007, 13(12):1753-1754. http://cn.bing.com/academic/profile?id=2428063060&encoded=0&v=paper_preview&mkt=zh-cn
[13]	Stanca CM, Fiel MI, Aledort L, et al. Factors associated with persistent thrombocytopenia after liver transplantation[J]. Transplant Proc, 2010, 42(5):1769-1773. doi: 10.1016/j.transproceed.2010.02.075
[14]	程龙宇, 俞军, 张武, 等.成人肝移植后发生持续性血小板减少的危险因素分析及其预防措施探讨[J].浙江大学学报(医学版), 2014, 43(6):670-677. http://d.wanfangdata.com.cn/periodical_zjdxxb-yxb201406009.aspx Cheng LY, Yu J, Zhang W, et al. Risk factors of persistent thrombocytopenia after adult liver transplantation and prophylactic measures[J]. J Zhejiang Univ (Med Sci), 2014, 43(6):670-677. http://d.wanfangdata.com.cn/periodical_zjdxxb-yxb201406009.aspx
[15]	Shimada M, Ijichi H, Yonemura Y, et al. The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft[J]. Hepatogastroenterology, 2004, 51(57):625-629. http://cn.bing.com/academic/profile?id=38784774&encoded=0&v=paper_preview&mkt=zh-cn
[16]	Ikegami T, Yoshizumi T, Soejima Y, et al. Application of splenectomy to decompress portal pressure in left lobe living donor liver transplantation[J]. Fukuoka Igaku Zasshi, 2013, 104(9):282-289. http://cn.bing.com/academic/profile?id=2417234243&encoded=0&v=paper_preview&mkt=zh-cn
[17]	Kim H, Suh KS, Jeon YM, et al. Partial splenic artery embolization for thrombocytopenia and uncontrolled massive ascites after liver transplantation[J]. Transplant Proc, 2012, 44(3):755-756. doi: 10.1016/j.transproceed.2012.01.066
[18]	Schimmer JA, van der Steeg AF, Zuidema WP. Splenic function after angioembolization for splenic trauma in children and adults: a systematic review[J]. Injury, 2016, 47(3):525-530. doi: 10.1016/j.injury.2015.10.047
[19]	Meighani A, Jafri SM, Raoufi M, et al. Splenic artery embolization for treatment of refractory ascites after liver transplantation[J]. ACG Case Rep J, 2016, 3(2):136-138. doi: 10.14309/crj.2016.25
[20]	Ikegami T, Shimada M, Imura S. Recent role of splenectomy in chronic hepatic disorders[J]. Hepatol Res, 2008, 38(12):1159-1171. http://cn.bing.com/academic/profile?id=1989250633&encoded=0&v=paper_preview&mkt=zh-cn
[21]	Murata K, Ito K, Yoneda K, et al. Splenectomy improves liver function in patients with liver cirrhosis[J]. Hepatogastroenterology, 2008, 55(85):1407-1411. http://cn.bing.com/academic/profile?id=2411318697&encoded=0&v=paper_preview&mkt=zh-cn
[22]	Tsoulfas G, Agorastou P. Commentary on "prophylaxis against HBV recurrence after liver transplantation for HBV-related endstage liver diseases with severe hypersplenism and splenomegaly: role of splenectomy"[J]. J Surg Res, 2013, 183(2):548-549. doi: 10.1016/j.jss.2012.04.065
[23]	Zhang Y, Yan L, Wen T, et al. Prophylaxis against hepatitis B virus recurrence after liver transplantation for hepatitis B virus-related end-stage liver diseases with severe hypersplenism and splenomegaly: role of splenectomy[J]. J Surg Res, 2012, 178(1):478-486. doi: 10.1016/j.jss.2012.02.047
[24]	de Ville de Goyet J, D'Ambrosio G, Grimaldi C. Surgical management of portal hypertension in children[J]. Semin Pediatr Surg, 2012, 21(3):219-232. doi: 10.1053/j.sempedsurg.2012.05.005
[25]	Sockrider CS, Boykin KN, Green J, et al. Partial splenic embolization for hypersplenism after liver transplantation[J]. Transplant Proc, 2001, 33(7/8):3472-3473. http://cn.bing.com/academic/profile?id=1973253942&encoded=0&v=paper_preview&mkt=zh-cn
[26]	Sockrider CS, Boykin KN, Green J, et al. Partial splenic embolization for hypersplenism before and after liver transplantation[J]. Clin Transplant, 2002, 16(Suppl 7):59-61. http://cn.bing.com/academic/profile?id=2040919805&encoded=0&v=paper_preview&mkt=zh-cn
[27]	Chu HC, Hsieh CB, Hsu KF, et al. Simultaneous splenectomy during liver transplantation augments anti-viral therapy in patients infected with hepatitis C virus[J]. Am J Surg, 2015, 209(1):180-186. doi: 10.1016/j.amjsurg.2014.03.004
[28]	Li DW, Du CY, Fan B, et al. Impact of simultaneous splenectomy and orthotopic liver transplantation in patients with end-stage liver diseases and splenic hyperfunction[J]. Hepatobiliary Pancreat Dis Int, 2012, 11(5):489-493. doi: 10.1016/S1499-3872(12)60212-4
[29]	Mousa A, Armbruster J, Adongay J, et al. Splenic artery embolization as a treatment option for chronic pancytopenia secondary to hypersplenism: a case report and review of literature[J]. Vasc Endovascular Surg, 2012, 46(6):501-503. doi: 10.1177/1538574412453347
[30]	Bárcena R, Gil-Grande L, Moreno J, et al. Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin[J]. Transplantation, 2005, 79(11):1634-1635. doi: 10.1097/01.TP.0000155424.52939.3D
[31]	Bárcena R, Moreno A, Foruny JR, et al. Improved graft function in liver-transplanted patients after partial splenic embolization: reversal of splenic artery steal syndrome?[J]. Clin Transplant, 2006, 20(4):517-523. doi: 10.1111/ctr.2006.20.issue-4
[32]	Ishikawa T, Kubota T, Horigome R, et al. Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve[J]. Hepatol Res, 2014, 44(11):1056-1061. doi: 10.1111/hepr.12222
[33]	Osaki A, Suda T, Waguri N, et al. Formula to predict platelet count after partial splenic arterial embolization in patients with hypersplenism[J]. J Vasc Interv Radiol, 2012, 23(7):900-907. doi: 10.1016/j.jvir.2012.03.008
[34]	Atici AE, Bostanci EB, Ozer I, et al. Use of granulocyte colony-stimulating factor for neutropenia after orthotopic liver transplantation: report of two cases[J]. Transplant Proc, 2011, 43(3):909-911. doi: 10.1016/j.transproceed.2010.11.019